Journals / Anadolu Kardiyoloji Dergisi / 2009 / Cilt: 9 - Sayı: 5

Sternotomili hastalarda göğüs ağrısı ve parestezinin tedavisinde diklofenaka karşı gabapentinin etkinliği

Efficacy of gabapentin versus diclofenac in the treatment of chest pain and paresthesia in patients with sternotomy

Pages
390–396
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In gabapentin group, mean pain and paresthesia scores regressed from 2.12±0.76 to 0.54±0.83 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chronic post-sternotomy chest pain and paresthesia (PCPP) are frequently seen and reduce the quality of life.
📊
Key Findings & Data:We aimed to demonstrate the efficacy and safety of gabapentin compared with diclofenac in the treatment of PCPP and to elucidate the similarities of PCPP to neuropathic pain syndromes.
💡
Conclusion & Impact:Results: In gabapentin group, mean pain and paresthesia scores regressed from 2.12±0.76 to 0.54±0.83 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Chronic post-sternotomy chest pain and paresthesia (PCPP) are frequently seen and reduce the quality of life. We aimed to demonstrate the efficacy and safety of gabapentin compared with diclofenac in the treatment of PCPP and to elucidate the similarities of PCPP to neuropathic pain syndromes. Methods: The prospective, randomized, open-label, blinded end-point design of study was used. One hundred and ten patients having PCPP lasting three months or more were randomized to receive 800 mg/daily gabapentin (n=55) and 75 mg/daily diclofenac (n=55) for thirty days. All patients have undergone cardiac surgery and median sternotomy. The perception of pain or paresthesia was evaluated as 0-Normal (no pain or paresthesia), 1-Mild, 2-Moderate, 3-Severe at baseline and after thirty days of treatment. Recurrences were questioned after three months. Statistical analyses were performed using independent samples t, Chi-square, continuity correction, Fisher’s exact, Mann Whitney U and Kruskal Wallis tests. Results: In gabapentin group, mean pain and paresthesia scores regressed from 2.12±0.76 to 0.54±0.83 (p

Özet

Amaç: Sternotomi sonrası kronik iskemik olmayan göğüs ağrısı ve parestezi (PCPP) sık görülmekte ve yaşam kalitesini azaltmaktadır. Bu çalışmada PCPP tedavisinde diklofenak ile karşılaştırıldığında gabapentinin etkinliği ve güvenilirliğini araştırmayı ve PCPP’nin nöropatik ağrı sendromlarıyla benzerliklerini aydınlatmayı amaçladık. Yöntemler: Çalışmada prospektif, randomize, açık işaretli, körleştirilmiş son nokta tasarımı kullanıldı. Üç ay ya da daha uzun sure PCPP’si olan 110 hasta 30 gün 800 mg/gün gabapentin (n=55) ve 75 mg/gün diklofenak (n=55) tedavisine randomize edildi. Ağrı ve parestezi algılaması 0-Normal, 1-Hafif, 2-Orta, 3-Şiddetli olarak başlangıçta ve 30. günde değerlendirildi. Üç ay sonra nüks sorgulandı. İstatistiksel analizde bağımsız örneklem t, Ki- kare, süreklilik düzeltmesi yapılmış Ki-kare değeri, Fisher kesinlik, Mann Whitney U ve Kruskal Wallis testleri kullanıldı. Bulgular: Gabapentin grubunda ortalama ağrı ve parestezi değerleri sırasıyla 2.12±0.762’den 0.54±0.83’e (p

🔖

Cite This Article

TAYYAR, N., GÜLCÜLER, M., KARABİGA, M., BIYIK, İ., ERGENE, O. (2022). Sternotomili hastalarda göğüs ağrısı ve parestezinin tedavisinde diklofenaka karşı gabapentinin etkinliği. Anadolu Kardiyoloji Dergisi, Cilt: 9 - Sayı: 5, 390–396. https://ajindex.com/articles/436896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lahtinen P, Kokki H, Hynynen M. Pain after cardiac surgery: a prospective cohort study of 1-year incidence and intensity. Anesthesiology 2006; 105: 794-800
  2. Meyerson J, Thelin S, Gordh T, Karlsten R. The incidence of chronic post-sternotomy pain after cardiac surgery-a prospective study. Acta Anaesthesiol Scand 2001; 45: 940-4
  3. Rowe MA, King KB. Long-term chest wall discomfort in women after coronary artery bypass grafting. Heart Lung 2003; 27: 184-8
  4. Kalso E, Mennander S, Tasmuth T, Nilsson E. Chronic poststernotomy pain. Acta Anaesthesiol Scand 2001; 45: 935-9
  5. Alston RP, Pechon P. Dysesthesia associated with sternotomy for heart surgery. Br J Anaesth 2005; 95: 153-8
  6. Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci 2006; 100: 471-86
  7. Barden J, Edwards J, Moore RA, McQuay HJ. Single dose oral diclofenac for postoperative pain. Cochrane Database Syst Rev 2004; 2: CD004768
  8. Hansson L, Hedner T, Dahlof B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press 1992; 1: 113-9
  9. Chapman JR, Syrjala KL. Measurement of pain. In: Loeser JD, editor. Bonica’s management of pain. Third edition. Philadelphia: Lippincott Williams Wilkins; 2001. p. 310-28
  10. Sihoe AD, Lee TW, Wan IY, Thung KH, Yim AP. The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. Eur J Cardiothorac Surg 2006; 29: 795-9
  11. King KM, Tsuyuki R, Faris P, Currie G, Maitland A, Collins-Nakai R. The Women's Recovery from Sternotomy (WREST) study: design of a randomized trial of a novel undergarment for early use after sternotomy. Am Heart J 2005; 149: 761-7
  12. King KM, Parry M, Southern D, Faris P, Tsuyuki RT. Women's Recovery from Sternotomy-Extension (WREST-E) study: examining long-term pain and discomfort following sternotomy and their predictors. Heart 2008; 94: 493-7
  13. Defalgue RJ, Bromley JJ. Poststernotomy neuralgia: A new pain syndrome. Anesth Analg 1989; 69: 81-2
  14. Conacher ID, Doig JC, Rivas L, Pridie AK. Intercostal neuralgia associated with internal mammary artery grafting. Anesthesia 1993; 48: 1070-1
  15. Eng J, Wells FC. Morbidity following coronary artery revascularization with the internal mammarian artery. Int J Cardiol 1991; 30: 55-9
  16. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic p